Dressing Wear Time After Breast Augmentation With Prosthesis
NCT ID: NCT01553604
Last Updated: 2019-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2013-07-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Time of Permanence of Dressing Following Breast Reconstruction
NCT01148823
Dressing Wear Time After Reduction Mammaplasty
NCT01002391
Physical Activity and Sexuality After Reduction Mammaplasty
NCT01297621
Sexuality After Reduction Mammaplasty
NCT01020422
Antibiotics After Breast Reduction:Clinical Trial With Randomization
NCT02569866
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Centers for Disease Control and Prevention (CDC) provides recommendations concerning prevention of SSI.No recommendation is offered for some practices, either because there is a lack of consensus regarding their efficacy or because of the available scientific evidence is insufficient to support their adoption.
CDC´s "Guideline for Prevention of Surgical Site Infection" recommends protecting with a sterile dressing for 24 to 48 hours an incision that has been closed primarily. There is no recommendation to cover the incision beyond 48 hours. One major risk factor for SSI is the presence of bacteria at surgical site.Thus, this trial was designed to verify the influence of dressing wear time on skin colonization.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Postoperative day 6
Dressing is removed on the sixth postoperative day
augmentation mammaplasty
Dressing is removed on the 6th postoperative day
Postoperative day 1
Dressing is removed on the first postoperative day
augmentation mammaplasty
Dressing is removed on the first postoperative day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
augmentation mammaplasty
Dressing is removed on the first postoperative day
augmentation mammaplasty
Dressing is removed on the 6th postoperative day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* body mass index under 30Kg/m2
Exclusion Criteria
* body mass index over 30Kg/m2
* breast cancer history
* previous breast surgery
* hard smoking
18 Months
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Daniela Francescato Veiga
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniela Francescato Veiga
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniela F Veiga, MD, PhD
Role: STUDY_DIRECTOR
Universidade Federal de São Paulo
Joel Veiga-Filho, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade do Vale do Sapucaí
Lydia M Ferreira, MD, PhD
Role: STUDY_CHAIR
Universidade Federal de São Paulo
Denise A Mendes, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal de São Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital das Clínicas Samuel Libanio
Pouso Alegre, Minas Gerais, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mendes Dde A, Veiga DF, Veiga-Filho J, Fonseca FE, de Paiva LF, Novo NF, Loyola AB, Ferreira LM. Application time for postoperative wound dressing following breast augmentation with implants: study protocol for a randomized controlled trial. Trials. 2015 Jan 27;16:19. doi: 10.1186/s13063-014-0529-5.
Mendes DA, Veiga DF, Veiga-Filho J, Loyola ABAT, Paiva LF, Novo NF, Sabino-Neto M, Ferreira LM. Influence of dressing application time after breast augmentation on cutaneous colonization: A randomized clinical trial. J Plast Reconstr Aesthet Surg. 2018 Jun;71(6):906-912. doi: 10.1016/j.bjps.2018.01.021. Epub 2018 Feb 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Micro02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.